SCHEMBL26986927

SCHEMBL26986927

CCC[C@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.59
▸ FYN P06241 1/20 0.59
▸ ADRA2A P08913 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ ADRA2B P18089 1/20 0.59
▸ DRD4 P21917 1/20 0.59
▸ DRD3 P35462 1/20 0.59
▸ CYP2D6 P10635 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ TSHR P16473 1/20 0.56
▸ CA2 P00918 13/20 0.55
▸ CA12 O43570 12/20 0.55
▸ CA1 P00915 12/20 0.55
▸ CA9 Q16790 8/20 0.55
▸ PKM P14618 1/20 0.53
▸ PTPN1 P18031 1/20 0.50
▸ CA4 P22748 8/20 0.49
▸ CA5A P35218 8/20 0.49
▸ CA7 P43166 8/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26224815 0.90 CYP2D6 (0.67) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL17366216 0.90 CYP2D6 (0.67) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL11167401 0.88 THRB (0.64) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL11170651 0.88 THRB (0.64) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL5948793 0.88 THRB (0.64) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL16506779 0.87 CYP2D6 (0.57) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL19090196 0.87 CYP2D6 (0.57) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL16506780 0.87 CYP2D6 (0.57) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL24297554 0.87 NR3C1 (0.62) NR3C1FYNADRA2AADORA3ADRA2B
SCHEMBL19778308 0.87 NR3C1 (0.62) NR3C1FYNADRA2AADORA3ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154188-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-05-15 — — US disclosed
EP-4551582-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS University of Pittsburgh - of the Commonwealth System of Higher Education (US) 2025-05-14 — — EP disclosed
CN-119816510-A C-glycosides as anti-inflammatory agents 匹兹堡大学联邦系统高等教育 2025-04-11 — — CN disclosed
WO-2024010959-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-01-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154188-A1 C-GLYCOSIDES AS ANTI-INFLAMMATORY AGENTS TLR4, TLR1, TLR6 NR3C1 48/4885FYN 2117/4885ADRA2A 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback